Naratriptan icorandil 4-dichlorophenyl)methyl]amino]-adenosine

4-dichlorophenyl)methyl]amino]-adenosine

resulting in constitutive activation

2-dicarboxamide

Molecular Weight: 255

It is also bioavailable and suitable for animal studies

Naratriptan icorandil 4-dichlorophenyl)methyl]amino]-adenosineNaratriptan is a selective 5 HT1 receptor subtype agonist for the treatment of migraine headache. Naratriptan binds with high affinity to human cloned 5 HT1B 1D receptors. Migraines are likely due to local cranial vasodilatation and or to the release of sensory neuropeptides (including substance P and calcitonin gene related peptide) through nerve endings in the trigeminal system. The therapeutic activity of AMERGE for the treatment of migraine